Jason C. Jones - Jan 28, 2021 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Chief Operating Officer
Signature
/s/ Jerome Wong, as Attorney-in-Fact
Stock symbol
EKSO
Transactions as of
Jan 28, 2021
Transactions value $
$0
Form type
4
Date filed
6/15/2023, 09:59 PM
Next filing
Apr 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Award $0 +20K +14.43% $0.00 159K Jun 12, 2023 Direct F1, F2, F3
transaction EKSO Common Stock Award $0 +170K +107.51% $0.00 329K Jun 12, 2023 Direct F1, F4, F5
transaction EKSO Common Stock Award $0 +1.15K $0.00 1.15K Jan 28, 2021 By 401K
transaction EKSO Common Stock Award $0 +3.35K +292.23% $0.00 4.49K Feb 17, 2022 By 401K
transaction EKSO Common Stock Award $0 +10.8K +240.48% $0.00 15.3K Jun 12, 2023 By 401K
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
F2 The RSU grant was approved by the Board of Directors in a meeting held on December 8, 2022, on the condition that the Issuer's stockholders approved an increase in shares available for issuance under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which occurred at the Issuer's Annual Meeting on June 8, 2023, and the Issuer filed a registration statement on Form S-8 with the Securities and Exchange Commission, which occurred on June 12, 2023. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of December 8, 2023, 2024 and 2025, in each case subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
F3 Includes 80,867 unvested RSUs.
F4 The RSU grant was approved by the Board of Directors in a meeting held on December 8, 2022, on the condition that the Issuer's stockholders approved an increase in shares available for issuance under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which occurred at the Issuer's Annual Meeting on June 8, 2023, and the Issuer filed a registration statement on Form S-8 with the Securities and Exchange Commission, which occurred on June 12, 2023. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of January 3, 2024, 2025 and 2026, in each case subject to the Reporting Person's continuous service with the Issuer as of each vesting date.
F5 Includes 251,141 unvested RSUs.